Global Tardive Dyskinesia (TD) Treatment Drugs Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 218186
  • calendar_today Published On: Nov, 2019
  • file_copy Pages: 101
  • list Pharmaceuticals and Healthcare

Scope of the Report:

The global Tardive Dyskinesia (TD) Treatment Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tardive Dyskinesia (TD) Treatment Drugs.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Tardive Dyskinesia (TD) Treatment Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Tardive Dyskinesia (TD) Treatment Drugs market by product type and applications/end industries.

Market Segment by Companies, this report covers

GlaxoSmithKline plc.

Bayer AG

Biogen

Teva Pharmaceutical Industries

Neurocrine Biosciences, Inc.

Pfizer Inc.

AstraZeneca

Novartis AG

Sanofi

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Valbenazine

Deutetrabenazine

Market Segment by Applications, can be divided into

Hospitals

Clinic

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Tardive Dyskinesia (TD) Treatment Drugs Market Overview

1.1 Product Overview and Scope of Tardive Dyskinesia (TD) Treatment Drugs

1.2 Classification of Tardive Dyskinesia (TD) Treatment Drugs by Types

1.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Comparison by Types (2019-2024)

1.2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Types in 2018

1.2.3 Valbenazine

1.2.4 Deutetrabenazine

1.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market by Application

1.3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Global Tardive Dyskinesia (TD) Treatment Drugs Market by Regions

1.4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Tardive Dyskinesia (TD) Treatment Drugs Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Tardive Dyskinesia (TD) Treatment Drugs Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tardive Dyskinesia (TD) Treatment Drugs Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Tardive Dyskinesia (TD) Treatment Drugs Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tardive Dyskinesia (TD) Treatment Drugs Status and Prospect (2014-2024)

1.5 Global Market Size of Tardive Dyskinesia (TD) Treatment Drugs (2014-2024)

2 Company Profiles

2.1 GlaxoSmithKline plc.

2.1.1 Business Overview

2.1.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.2 Bayer AG

2.2.1 Business Overview

2.2.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.3 Biogen

2.3.1 Business Overview

2.3.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.4 Teva Pharmaceutical Industries

2.4.1 Business Overview

2.4.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.5 Neurocrine Biosciences, Inc.

2.5.1 Business Overview

2.5.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.6 Pfizer Inc.

2.6.1 Business Overview

2.6.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.7 AstraZeneca

2.7.1 Business Overview

2.7.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.8 Novartis AG

2.8.1 Business Overview

2.8.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

2.9 Sanofi

2.9.1 Business Overview

2.9.2 Tardive Dyskinesia (TD) Treatment Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Revenue, Gross Margin and Market Share (2017-2018)

3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Competition, by Players

3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Tardive Dyskinesia (TD) Treatment Drugs Players Market Share

3.2.2 Top 10 Tardive Dyskinesia (TD) Treatment Drugs Players Market Share

3.3 Market Competition Trend

4 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions

4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue and Market Share by Regions

4.2 North America Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

4.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

4.5 South America Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

5 North America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries

5.1 North America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries (2014-2019)

5.2 USA Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

5.3 Canada Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

5.4 Mexico Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

6 Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries

6.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries (2014-2019)

6.2 Germany Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

6.3 UK Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

6.4 France Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

6.5 Russia Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

6.6 Italy Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries

7.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries (2014-2019)

7.2 China Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

7.3 Japan Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

7.4 Korea Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

7.5 India Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

8 South America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries

8.1 South America Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries (2014-2019)

8.2 Brazil Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

8.3 Argentina Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

8.4 Colombia Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Tardive Dyskinesia (TD) Treatment Drugs by Countries

9.1 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue by Countries (2014-2019)

9.2 Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

9.3 UAE Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

9.4 Egypt Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

9.5 Nigeria Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

9.6 South Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue and Growth Rate (2014-2019)

10 Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment by Type

10.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue and Market Share by Type (2014-2019)

10.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Type (2019-2024)

10.3 Valbenazine Revenue Growth Rate (2014-2024)

10.4 Deutetrabenazine Revenue Growth Rate (2014-2024)

11 Global Tardive Dyskinesia (TD) Treatment Drugs Market Segment by Application

11.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Application (2014-2019)

11.2 Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Clinic Revenue Growth (2014-2019)

11.5 Others Revenue Growth (2014-2019)

12 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2024)

12.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2024)

12.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Forecast by Regions (2019-2024)

12.3 North America Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Forecast (2019-2024)

12.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Forecast (2019-2024)

12.6 South America Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Tardive Dyskinesia (TD) Treatment Drugs Picture

Table Product Specifications of Tardive Dyskinesia (TD) Treatment Drugs

Table Global Tardive Dyskinesia (TD) Treatmen

Please fill the form below, to recieve the report sample


+1